Literature DB >> 18178803

Renal insufficiency and mortality in patients with known or suspected coronary artery disease.

Ron T van Domburg1, Sanne E Hoeks, Gijs M J M Welten, Michel Chonchol, Abdou Elhendy, Don Poldermans.   

Abstract

It remains unclear whether mild renal dysfunction is associated with adverse cardiovascular outcome. We investigated whether estimated glomerular filtration rate (eGFR) was associated with mortality and cardiac death among 6447 patients with known or suspected coronary artery disease over a mean follow-up of 7 yr. Cumulative 5- and 10-yr survival rates decreased in a graded fashion from 88% and 70%, respectively, for those with normal renal function to 43% and 33% for those with eGFR <30 ml/min. Compared with patients with normal renal function, the multivariable adjusted hazard ratios for all-cause mortality among patients with mild, moderate, and severe renal impairment were 1.33 (95% confidence interval [CI], 1.21-1.48), 1.67 (95% CI, 1.44-1.93), and 3.38 (95% CI, 2.73-4.19), respectively. Similar relationships between cardiac death and decreasing renal function were found. In conclusion, renal function is a graded and independent predictor of long-term mortality in patients with known or suspected coronary artery disease. Intense treatment and close surveillance of these patients is encouraged.

Entities:  

Mesh:

Year:  2008        PMID: 18178803      PMCID: PMC2391035          DOI: 10.1681/ASN.2006101112

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  26 in total

Review 1.  Serum creatinine as an index of renal function: new insights into old concepts.

Authors:  R D Perrone; N E Madias; A S Levey
Journal:  Clin Chem       Date:  1992-10       Impact factor: 8.327

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.

Authors:  B F Culleton; M G Larson; P W Wilson; J C Evans; P S Parfrey; D Levy
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

4.  Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study.

Authors:  L P Fried; R A Kronmal; A B Newman; D E Bild; M B Mittelmark; J F Polak; J A Robbins; J M Gardin
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

5.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

6.  Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group.

Authors:  M Jonas; H Reicher-Reiss; V Boyko; A Shotan; L Mandelzweig; U Goldbourt; S Behar
Journal:  Am J Cardiol       Date:  1996-06-15       Impact factor: 2.778

7.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

8.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

9.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Authors:  Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

10.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

View more
  14 in total

1.  Cardiovascular disease: World Kidney Day 2011: protect your kidneys, save your heart.

Authors:  William G Couser; Miguel C Riella
Journal:  Nat Rev Nephrol       Date:  2011-03       Impact factor: 28.314

Review 2.  World Kidney Day 2011: protect your kidneys, save your heart.

Authors:  William G Couser; Miguel C Riella
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

Review 3.  A focused review on optimal coronary revascularisation in patients with chronic kidney disease: Coronary revascularisation in kidney disease.

Authors:  Andie H Djohan; Ching-Hui Sia; Joshua Ping-Yun Loh
Journal:  AsiaIntervention       Date:  2019-02-20

4.  Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.

Authors:  Dirk De Bacquer; Delphine De Smedt; Kornelia Kotseva; Catriona Jennings; David Wood; Lars Rydén; Viveca Gyberg; Bahira Shahim; Philippe Amouyel; Jan Bruthans; Almudena Castro Conde; Renata Cífková; Jaap W Deckers; Johan De Sutter; Mirza Dilic; Maryna Dolzhenko; Andrejs Erglis; Zlatko Fras; Dan Gaita; Nina Gotcheva; John Goudevenos; Peter Heuschmann; Aleksandras Laucevicius; Seppo Lehto; Dragan Lovic; Davor Miličić; David Moore; Evagoras Nicolaides; Raphael Oganov; Andrzej Pajak; Nana Pogosova; Zeljko Reiner; Martin Stagmo; Stefan Störk; Lale Tokgözoğlu; Dusko Vulic; Martin Wagner; Guy De Backer
Journal:  Eur J Epidemiol       Date:  2018-10-23       Impact factor: 8.082

5.  Relationship of serum bilirubin concentration to kidney function and 24-hour urine protein in Korean adults.

Authors:  Ho Sik Shin; Yeon Soon Jung; Hark Rim
Journal:  BMC Nephrol       Date:  2011-06-28       Impact factor: 2.388

6.  World Kidney Day 2011 - Protect your kidneys, save your heart.

Authors:  William G Couser; Miguel C Riella
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

7.  Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.

Authors:  Beata Franczyk-Skóra; Anna Gluba; Maciej Banach; Jacek Rysz
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

8.  Impact of renal dysfunction on clinical outcomes of acute coronary syndrome.

Authors:  Yong Un Kang; Myung Ho Jeong; Soo Wan Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

9.  Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9.

Authors:  Ta-Wei Hsu; Ko-Lin Kuo; Szu-Chun Hung; Po-Hsun Huang; Jaw-Wen Chen; Der-Cherng Tarng
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial.

Authors:  Viktor V Chirikov; Chris Walker; Jennifer M Stephens; Patricia Schepman; Richard Chambers; Mahmoud Bakir; Gregory W Poorman; Seema Haider; Mohammed Farghaly
Journal:  Clinicoecon Outcomes Res       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.